These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8786409)

  • 21. Reduced CSF PLTP activity in Alzheimer's disease and other neurologic diseases; PLTP induces ApoE secretion in primary human astrocytes in vitro.
    Vuletic S; Peskind ER; Marcovina SM; Quinn JF; Cheung MC; Kennedy H; Kaye JA; Jin LW; Albers JJ
    J Neurosci Res; 2005 May; 80(3):406-13. PubMed ID: 15795933
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A continuum receptor model of hepatic lipoprotein metabolism.
    Tindall MJ; Wattis JA; O'Malley BJ; Pickersgill L; Jackson KG
    J Theor Biol; 2009 Apr; 257(3):371-84. PubMed ID: 19109979
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In the absence of the low density lipoprotein receptor, human apolipoprotein C1 overexpression in transgenic mice inhibits the hepatic uptake of very low density lipoproteins via a receptor-associated protein-sensitive pathway.
    Jong MC; Dahlmans VE; van Gorp PJ; van Dijk KW; Breuer ML; Hofker MH; Havekes LM
    J Clin Invest; 1996 Nov; 98(10):2259-67. PubMed ID: 8941642
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peripheral versus central nervous system APOE in Alzheimer's disease: Interplay across the blood-brain barrier.
    Chernick D; Ortiz-Valle S; Jeong A; Qu W; Li L
    Neurosci Lett; 2019 Aug; 708():134306. PubMed ID: 31181302
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Predictive value of apolipoproteine E genotypes].
    Martenka J; Soszyńska K
    Wiad Lek; 2016; 69(3 pt 2):569-575. PubMed ID: 28478428
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Central Nervous System Lipoproteins: ApoE and Regulation of Cholesterol Metabolism.
    Mahley RW
    Arterioscler Thromb Vasc Biol; 2016 Jul; 36(7):1305-15. PubMed ID: 27174096
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ApoE and cerebral insulin: Trafficking, receptors, and resistance.
    Rhea EM; Raber J; Banks WA
    Neurobiol Dis; 2020 Apr; 137():104755. PubMed ID: 31978603
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Apolipoprotein E polymorphism and susceptibility to Alzheimer's disease.
    Kamboh MI
    Hum Biol; 1995 Apr; 67(2):195-215. PubMed ID: 7729825
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Roles for lipoprotein lipase in Alzheimer's disease: an association study.
    Baum L; Wiebusch H; Pang CP
    Microsc Res Tech; 2000 Aug; 50(4):291-6. PubMed ID: 10936883
    [TBL] [Abstract][Full Text] [Related]  

  • 30. No association between very low density lipoprotein receptor (VLDL-R) and Alzheimer disease in American Caucasians.
    Pritchard ML; Saunders AM; Gaskell PC; Small GW; Conneally PM; Rosi B; Yamaoka LH; Roses AD; Haines JL; Pericak-Vance MA
    Neurosci Lett; 1996 May; 209(2):105-8. PubMed ID: 8761993
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Membrane binding sites for plasma lipoproteins on endosomes from rat liver.
    Jaeckle S; Brady SE; Havel RJ
    Proc Natl Acad Sci U S A; 1989 Mar; 86(6):1880-4. PubMed ID: 2538819
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functions of lipoprotein receptors in neurons.
    Beffert U; Stolt PC; Herz J
    J Lipid Res; 2004 Mar; 45(3):403-9. PubMed ID: 14657206
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The ApoE receptors Vldlr and Apoer2 in central nervous system function and disease.
    Lane-Donovan C; Herz J
    J Lipid Res; 2017 Jun; 58(6):1036-1043. PubMed ID: 28292942
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Very low density lipoprotein receptor in Alzheimer disease.
    Helbecque N; Amouyel P
    Microsc Res Tech; 2000 Aug; 50(4):273-7. PubMed ID: 10936879
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression and alternate splicing of apolipoprotein E receptor 2 in brain.
    Clatworthy AE; Stockinger W; Christie RH; Schneider WJ; Nimpf J; Hyman BT; Rebeck GW
    Neuroscience; 1999 Mar; 90(3):903-11. PubMed ID: 10218790
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression and regulation of apolipoprotein E receptors in the cells of the central nervous system in culture: A review.
    Fan QW; Iosbe I; Asou H; Yanagisawa K; Michikawa M
    J Am Aging Assoc; 2001 Jan; 24(1):1-10. PubMed ID: 23604870
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Apolipoprotein E uptake and degradation via chloroquine-sensitive pathway in cultivated monkey cells overexpressing low density lipoprotein receptor.
    Jensen TG; Roses AD; Jørgensen AL
    Neurosci Lett; 1994 Oct; 180(2):193-6. PubMed ID: 7700578
    [TBL] [Abstract][Full Text] [Related]  

  • 38. More than cholesterol transporters: lipoprotein receptors in CNS function and neurodegeneration.
    Lane-Donovan C; Philips GT; Herz J
    Neuron; 2014 Aug; 83(4):771-87. PubMed ID: 25144875
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alterations in apolipoprotein E expression during aging and neurodegeneration.
    Masliah E; Mallory M; Veinbergs I; Miller A; Samuel W
    Prog Neurobiol; 1996 Dec; 50(5-6):493-503. PubMed ID: 9015824
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of apolipoprotein E in lipid metabolism in the central nervous system.
    Han X
    Cell Mol Life Sci; 2004 Aug; 61(15):1896-906. PubMed ID: 15289932
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.